AU2003903382A0 - Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof - Google Patents

Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof

Info

Publication number
AU2003903382A0
AU2003903382A0 AU2003903382A AU2003903382A AU2003903382A0 AU 2003903382 A0 AU2003903382 A0 AU 2003903382A0 AU 2003903382 A AU2003903382 A AU 2003903382A AU 2003903382 A AU2003903382 A AU 2003903382A AU 2003903382 A0 AU2003903382 A0 AU 2003903382A0
Authority
AU
Australia
Prior art keywords
calcitriol
mediated
inhibition
compounds therefor
induction screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003903382A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Priority to AU2003903382A priority Critical patent/AU2003903382A0/en
Publication of AU2003903382A0 publication Critical patent/AU2003903382A0/en
Priority to PCT/AU2004/000912 priority patent/WO2005003358A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
AU2003903382A 2003-07-03 2003-07-03 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof Abandoned AU2003903382A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003903382A AU2003903382A0 (en) 2003-07-03 2003-07-03 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof
PCT/AU2004/000912 WO2005003358A1 (en) 2003-07-03 2004-07-02 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefore and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003903382A AU2003903382A0 (en) 2003-07-03 2003-07-03 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof

Publications (1)

Publication Number Publication Date
AU2003903382A0 true AU2003903382A0 (en) 2003-07-17

Family

ID=31983016

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003903382A Abandoned AU2003903382A0 (en) 2003-07-03 2003-07-03 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof

Country Status (2)

Country Link
AU (1) AU2003903382A0 (en)
WO (1) WO2005003358A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE029572T2 (en) 2006-02-03 2017-03-28 Opko Renal Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
EP3542792B1 (en) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Controlled release 25-hydroxyvitamin d
KR101495578B1 (en) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 Method of treating vitamin d insufficiency and deficiency
KR101852042B1 (en) * 2008-04-02 2018-04-25 사이토크로마 인코포레이티드 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
LT2552484T (en) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Methods and compositions for reducing parathyroid levels
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
CN114681468A (en) 2014-08-07 2022-07-01 欧普科爱尔兰环球控股有限公司 Adjunctive therapy with 25-hydroxyvitamin D
TW202214257A (en) 2016-03-28 2022-04-16 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 Methods of vitamin d treatment

Also Published As

Publication number Publication date
WO2005003358A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
AU2003303250A1 (en) Quantification of operational risks
AU2003302137A8 (en) Quality control of assays
AU2003228536A1 (en) Methods for separation and detection of ketosteroids and other carbonyl-containing compounds
AU2003269126A1 (en) Method of combining materials
AU2003903382A0 (en) Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof
AU2003901361A0 (en) Method of enhancing fluorescence
AU2003220930A1 (en) Emthod of screening transporter inhibitor
AU2003902178A0 (en) Stabilization of waste material
AU2003297743A1 (en) Method of making tricyclic aminocyanopyridine compounds
AU2003254579A1 (en) Methods of screening for schizophrenia
GB0212853D0 (en) Separation of molecules
AU2003244764A1 (en) Direct pcr quantification
EP1743944A4 (en) Novel method of screening
AU2003903274A0 (en) Method of assessing cancer risk
PL1622926T3 (en) Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds
EP1650562A4 (en) Method of screening useful protein
AU2003264441A1 (en) Method of screening remedy for proliferative disease
GB0220894D0 (en) Method of separation
AU2003290512A1 (en) Method of weldbonding
AU2002951561A0 (en) Marker for early stage cancer screening
AU2004905143A0 (en) Method of screening
EP1865325A4 (en) Method of screening for cancer and adenoma
GB0427692D0 (en) Improvement of sludge quality
AU2003241904A1 (en) Novel method of screening
GB0307280D0 (en) Screening of compounds